The role of interleukin-1 in general pathology

N Kaneko, M Kurata, T Yamamoto, S Morikawa… - Inflammation and …, 2019 - Springer
Abstract Interleukin-1, an inflammatory cytokine, is considered to have diverse physiological
functions and pathological significances and play an important role in health and disease. In …

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

CA Dinarello, A Simon… - Nature reviews Drug …, 2012 - nature.com
Abstract Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain
thresholds and damages tissues. Monotherapy blocking IL-1 activity in autoinflammatory …

Treating inflammation by blocking interleukin-1 in humans

CA Dinarello, JWM van der Meer - Seminars in immunology, 2013 - Elsevier
IL-1 is a master cytokine of local and systemic inflammation. With the availability of specific
IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL …

Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice

JJ Chae, YH Cho, GS Lee, J Cheng, PP Liu… - Immunity, 2011 - cell.com
Missense mutations in the C-terminal B30. 2 domain of pyrin cause familial Mediterranean
fever (FMF), the most common Mendelian autoinflammatory disease. However, it remains …

The NLRP3 inflammasome in health and disease: the good, the bad and the ugly

P Menu, JE Vince - Clinical & Experimental Immunology, 2011 - academic.oup.com
Summary While interleukin (IL)-1β plays an important role in combating the invading
pathogen as part of the innate immune response, its dysregulation is responsible for a …

[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …

KL Winthrop, X Mariette, JT Silva, E Benamu… - Clinical Microbiology …, 2018 - Elsevier
Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …

Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies

G Cavalli, CA Dinarello - Rheumatology, 2015 - academic.oup.com
The inflammatory cytokines IL-1α and IL-1β orchestrate local and systemic inflammatory
responses underlying a broad spectrum of diseases. Three agents for reducing IL-1 …

Interleukin-1, inflammasomes, autoinflammation and the skin

E Contassot, HD Beer, LE French - Swiss medical weekly, 2012 - smw.ch
Interleukin 1, one of the first cytokines discovered in the 1980s, and a potent mediator of
fever, pain and inflammation, is at present experiencing a revival in biology and medicine …

Rilonacept for colchicine-resistant or-intolerant familial Mediterranean fever: a randomized trial

PJ Hashkes, SJ Spalding, EH Giannini… - Annals of internal …, 2012 - acpjournals.org
Chinese translation This article has been corrected. The original version (PDF) is appended
to this article as a Supplement. Background: Currently, there is no proven alternative therapy …

Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature

U Meinzer, P Quartier, JF Alexandra, V Hentgen… - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVES: Familial Mediterranean fever (FMF) is an autosomal-recessive
autoinflammatory disorder common in Mediterranean populations. FMF is associated with …